Conference Proceedings
Patients' and their doctors' preferences for adjuvant sorafenib after resection of intermediate to high risk RCC: what makes it worthwhile?
S Sengupta, P Blinman, J Thompson, T France, A Martin, I Davis, M Stockler
BJU International | WILEY-BLACKWELL | Published : 2013